Open company graph database — free web & API
Login

Precision System Science Co., Ltd.

プレシジョン・システム・サイエンス株式会社
Ticker
Listed market
TYO
Country
Japan
Employees (consolidated)
151
Related companies
5
§01

Basic information

BASIC
Head office
88 Kamihongō, Matsudo City, Chiba Prefecture
Chief executive
Yuu Sugiyama
Capital
100,000,000
Employees (non-consolidated)
88 people
Employees (consolidated)
151 people
Start date
1985-07-17
End date
§02

Websites

1 DOMAINS
§03

Business

12
Development, manufacturing, and sales of test and diagnostic systems in the biopharmaceutical field.EquipmentSoftwareReagentsConsumablesMaintenanceContract testingmagLEAD seriesgeneLEAD seriesLuBEA seriesLecChip seriesReagent lineup
§04

Related companies

5 COMPANIES
Company name Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
Precision System Science Europe Ltd.
Group
つくばラボラトリー
Group
NPSS Corporation
Group
NPSS Corporation
Group
大館試薬センター
Names without a link are companies not yet registered in OpenBizGraph
§05

Network

NETWORK
Drag to move · click to open
§06

History

106 EVENTS

Established in Itabashi-ku, Tokyo, for the purpose of maintenance and servicing of physical and chemical equipment (clinical laboratory instruments).Sources

Founded as a maintenance and service company for clinical laboratory instruments at Itabashi-Ku, Tokyo.Sources

Relocated headquarters to Fuchu City, Tokyo.Sources

The Head Office was transferred to Fuchu-city, Tokyo.Sources

Commenced manufacturing and sales of in-house products such as dispensing, dilution, and cleaning equipment for physical and chemical instruments.Sources

Starting the production and sales of clinical laboratory instruments such as fractionating devices, dilution apparatuses and washing apparatuses started as PSS own products.Sources

Established Matsudo Research Laboratory in Matsudo City, Chiba Prefecture as a research and development facility.Sources

Matsudo Research Laboratory was founded in Matsudo, Chiba, as a research and development facility.Sources

Relocated headquarters to Inagi City, Tokyo.Sources

The Head Office was transferred to Inagi-city, Tokyo.Sources

Successfully commercialized a chemiluminescent immunoassay device (HiMICO) using magnetic particle method. Filed patents for the development technology in Japan, the United States, Europe, and other countries worldwide, naming it MagTraction Technology.Sources

Successfully commercialized the immunochemical luminescence measuring system (HiMICO) using magnetic particles technology. The invented technology was applied for patent in various countries including Japan, U.S., and Europe, and was named "Magtration : ® : Technology".Sources

Successfully commercialized the immunochemical luminescence measuring system (HiMICO) using magnetic particles technology. The invented technology was applied for patent in various countries including Japan, U.S., and Europe, and was named 'Magtration Technology'.Sources

Successfully commercialized DNA automatic extraction devices and related products using MagTraction Technology.Sources

Successfully commercialized the automated DNA extraction system using the Magtration : ® : Technology.Sources

Successfully commercialized the automated DNA extraction system using the Magtration Technology.Sources

Entered into an OEM agreement with Toyo Bōseki Co., Ltd. regarding DNA automatic extraction devices and related products.Sources

Entered an OEM contract as for Automated DNA extraction system and others with TOYOBO. Co., Ltd. (JAPAN).Sources

Signed an OEM agreement with Swiss F. Hoffmann-La Roche Ltd regarding DNA automatic extraction devices, etc.Sources

Entered an OEM contract as for Automated DNA extraction system and others with F. Hoffmann-La Roche Ltd. (Switzerland).Sources

Signed an OEM agreement with German Boehringer Mannheim GmbH (currently Roche Diagnostics Ltd (Switzerland)) regarding DNA automatic extraction devices, etc.Sources

Entered an OEM contract as for Automated DNA extraction system and others with Boehringer Mannheim GmbH (Germany) (currently, Roche Diagnostics Ltd. (Switzerland)).Sources

Signed an OEM agreement with Norwegian GenoVision AS (now Qiagen AS) regarding DNA automatic extraction devices, etc.Sources

Entered an OEM contract as for Automated DNA extraction system and others with GenoVision AS (Norway) (currently, Qiagen AS).Sources

The Japanese Red Cross Society introduced NAT testing (Nucleic Acid Amplification Test) for blood donations for the first time in the world, utilizing PSS's OEM supplied product (nucleic acid automatic extraction device), which significantly reduced the incidence of post-transfusion hepatitis, thereby contributing to society.Sources

Japan Red Cross implemented 'NAT test(Nucleic Acids Amplification test)' to donated blood for the first time in the world, and the PSS system was the answer. PSS is a leader in helping to reduce serum hepatitis incidence after transfusions.Sources

Signed an OEM agreement with Swedish Magnetic Biosolution Sweden AB regarding DNA automatic extraction devices, etc.Sources

Entered an OEM contract as for Automated DNA extraction system and others with Magnetic Biosolution Sweden AB (Sweden).Sources

Listed shares on the Osaka Stock Exchange Nasdaq Japan Market (now JASDAQ Market).Sources

IPO at OSE NASDAQ Japan Market (currently "JASDAQ" Market).Sources

IPO at OSE NASDAQ Japan Market (currently 'JASDAQ' Market).Sources

Integrated the headquarters in Inajō City with the Matsudo Research Institute into a new headquarters building, relocating the headquarters to Matsudo City, Chiba Prefecture.Sources

Head Office transferred to Matsudo-city, Chiba, where all facilities including Matsudo Research Laboratory were incorporated in the new office building.Sources

Established U.S. subsidiary PSS Bio Instruments, Inc. (California, USA; renamed Precision System Science USA, Inc. in July 2007, dissolved March 2025) and European subsidiary Precision System Science Europe GmbH (Munich, Germany; currently Düsseldorf, Germany).Sources

Established PSS Bio Instruments, Inc. (California,U.S.A. July 2007: Renamed to Precision System Science USA, Inc.,dissolved in March 2025) and : Precision System Science Europe GmbH : (initially located in Mainz, Germany; now in Düsseldorf, Germany).Sources

Established PSS Bio Instruments, Inc. (California, U.S.A.) and Precision System Science Europe GmbH (initially located in Mainz, Germany; now in Düsseldorf, Germany).Sources

Established subsidiary Universal Bio Research Co., Ltd. (Matsudo City, Chiba Prefecture) (excluded from consolidation due to share transfer in January 2025).Sources

Established Universal Bio Research Co., Ltd. (Matsudo, Chiba, Japan); excluded from consolidation after share transfer in January 2025.Sources

Signed an OEM agreement with Norwegian Qiagen AS and German Qiagen GmbH regarding DNA automatic extraction devices, etc. (currently renewed contract with Swiss Qiagen Instruments AG).Sources

Signed an OEM agreement with Mitsubishi Chemical Yatron Co., Ltd. (now LSI Medience Co., Ltd.) regarding a small-scale immunochemical luminescence measurement device.Sources

- 2004 : August : Entered an OEM contract as for compact immunochemical luminescence measuring system with Mitsubishi Kagaku Iatron Inc. (currently, LSI Medience Corp.).Sources

Entered an OEM contract as for compact immunochemical luminescence measuring system with Mitsubishi Kagaku Iatron Inc. (currently, LSI Medience Corp.).Sources

Signed an OEM agreement with Invitrogen Corporation (now Life Technologies Corporation) regarding DNA automatic extraction devices, etc.Sources

- 2006 : May : Entered an OEM contract as for Automated DNA extraction system and others with Invitrogen Corporation (U.S.) (currently, Life Technologies Corporation).Sources

Entered an OEM contract as for Automated DNA extraction system and others with Invitrogen Corporation (U.S.) (currently, Life Technologies Corporation).Sources

Established subsidiary PSS Capital Co., Ltd. as an investment company, under which the Bio Content Investment Business LLC is established and operated.Sources

Signed an OEM agreement with Bechman Coulter, Inc. (USA) regarding DNA automatic extraction devices, etc.Sources

Signed an OEM agreement with NanoString Technologies, Inc. (USA) regarding sample purification and reaction processing systems.Sources

- 2007 : February : Entered an OEM contract as for sample purification-reaction treatment system with NanoString Technologies, Inc. (U.S.)Sources

Entered an OEM contract as for sample purification-reaction treatment system with NanoString Technologies, Inc. (U.S.)Sources

Signed a domestic exclusive sales agreement with GE Healthcare BioScience Co., Ltd. for protein automatic purification devices and reagent kits (Purelumn system).Sources

Collaborated with Belgian Diagenode SA and Nippon Gene Co., Ltd. on the development of automation systems for epigenetics.Sources

- 2008 : April : Entered a collaboration with Diagenode SA (Belgium) and Nippon Gene Co., Ltd. in development of automated system for epigenetics.Sources

Entered a collaboration with Diagenode SA (Belgium) and Nippon Gene Co., Ltd. in development of automated system for epigenetics.Sources

Acquired a portion of shares in NPS Co., Ltd. (applying the equity method) and established a partnership with Japan Pulse Motor Co., Ltd.Sources

- 2009 : September : PSS invested in NPS Co., Ltd. (affiliated company accounted for by the equity method) and collaboration agreement with Nippon Pulse Motor Co., Ltd.Sources

PSS invested in NPS Co., Ltd. (affiliated company accounted for by the equity method) and collaboration agreement with Nippon Pulse Motor Co., Ltd.Sources

Transitioned to the JASDAQ Standard Market.Sources

- 2010 : October : We moved to JASDAQ(Standard) Listed market.Sources

We moved to JASDAQ(Standard) Listed market.Sources

Signed a development agreement with DiaSorin for a molecular diagnostic device using the LAMP method.Sources

- 2011 : April : PSS reaches an agreement with DiaSorin to develop a molecular diagnostic analyzer for LAMP.Sources

PSS reaches an agreement with DiaSorin to develop a molecular diagnostic analyzer for LAMP.Sources

Signed a contract with Abbott for the development of fully automated pretreatment devices for automated bacterial testing systemsSources

- 2012 : March : PSS reaches Development Agreement with Abbott.Sources

PSS reaches Development Agreement with Abbott.Sources

Signed a joint development and sales supply agreement with ELITechGroup for the fully automated gene analysis system "geneLEAD"Sources

- 2013 : April : PSS and ELITech Group enter into a Joint Development, Distribution and Supply Agreement on PSS's 'geneLEAD', a fully automated, sample-to-result, Real-Time PCR analyzer.Sources

PSS and ELITech Group enter into a Joint Development, Distribution and Supply Agreement on PSS's 'geneLEAD', a fully automated, sample-to-result, Real-Time PCR analyzer.Sources

Transitioned to the Tokyo Stock Exchange JASDAQ Standard Market due to the integration of the Osaka Securities Exchange and Tokyo Stock ExchangeSources

- July : Due to the merger between (OSE) Hercules and JASDAQ, PSS was listed on TSE JASDAQ (Standard) market.Sources

Signed a supply and sales agreement with LG Life Sciences in Korea regarding the fully automated gene analysis system "geneLEAD"Sources

Signed an OEM agreement with Roka in the United States for genetic testing systems for food inspectionSources

- 2014 : May : PSS and Roka Bioscience enter into an OEM Agreement on Development of Automated Molecular Diagnostics System.Sources

PSS and Roka Bioscience enter into an OEM Agreement on Development of Automated Molecular Diagnostics System.Sources

Signed a product supply agreement for specimen pretreatment systems for AbbottSources

- October : PSS reaches Agreement to Supply Abbott with Two Types of Sample Prep System.Sources

PSS Odate Reagent Center operationalSources

- November : Started operation of PSS Odate Reagent CenterSources

Signed an OEM supply agreement with ELITechGroup for the fully automated genetic diagnostic system "geneLEAD XII"Sources

- December : PSS and ELITechGroup reach OEM Agreement on 'geneLEAD XII' a fully automated, sample-to-result, Real-Time PCR system.Sources

Changed market to Tokyo Stock Exchange MothersSources

- 2015 : September : We moved to Mothers Listed market.Sources

We moved to Mothers Listed market.Sources

Acquired additional shares of NPS Inc. and made it a wholly owned subsidiarySources

- 2016 : June : PSS obtained additional stocks of NPS Co., Ltd. and made it a wholly owned subsidiary.Sources

PSS obtained additional stocks of NPS Co., Ltd. and made it a wholly owned subsidiary.Sources

Capital and business alliance with Hitachi High-Technologies Corporation, issuance of new shares through third-party allotmentSources

- 2017 : May : Capital & business alliance with Hitachi High-Technologies Corporation, issuance of new shares through third-party allotment.Sources

Capital & business alliance with Hitachi High-Technologies Corporation, issuance of new shares through third-party allotment.Sources

Received a letter of appreciation from the French Ambassador to Japan for supplying fully automated PCR testing systemsSources

- 2020 : April : Received a letter of appreciation from the French Ambassador to Japan for the supply of a fully automated PCR testing system.Sources

Received a letter of appreciation from the French Ambassador to Japan for the supply of a fully automated PCR testing system.Sources

Adopted the subsidy for domestic investment promotion projects for supply chain countermeasuresSources

- July : Received 'Subsidy for Domestic Investment Promotion Project for Supply Chain Measures'.Sources

Launched sales of fully automated PCR testing devices and PCR reagents for COVID-19 (SARS-CoV-2) testing in JapanSources

- August : Fully automated PCR testing system and PCR reagents for 'COVID-19 (SARS-CoV-2)' test are launched in Japan.Sources

Received the Nikkei Excellent Product & Service Award: Nikkei Industry Newspaper Award for the fully automated PCR testing system "Elite Ingenious" and the 63rd Top 10 New Products Award: Nikkan Kogyo Shimbun for "GeneRead Eight" in 2020Sources

Receives the NIKKEI BUSINESS DAILY Award for the Nikkei Superior Products and Services Award 2020 for the fully automated PCR testing system "ELITe InGenius" and the THE NIKKAN KOGYO SHIMBUN Award 63rd New Product Award 2020 for "geneLEAD VIII".Sources

Registered PSS Shinjuku Laboratory (Shinjuku-ku, Tokyo) as a sanitary inspection office (closed in May 2024)Sources

Transitioned to the Growth Market due to review of Tokyo Stock Exchange market classificationSources

Moves to the Growth Market in accordance with the revision of the Tokyo Stock Exchange's market classification.Sources

Commissioned the second factory of PSS Odate Reagent CenterSources

Established a joint venture, PF・BioLine, with Ferrotec Holdings Corporation (liquidation completed in March 2025)Sources

Absorbed and succeeded the reagent manufacturing and consumables manufacturing business operated by NPS Inc. through a simplified absorption-type company splitSources

Assumed the reagent and consumables manufacturing business of NPS Co., Ltd. through a simplified absorption-type split.Sources

§07

News

25 ARTICLES

Precision System Science Consolidated Financial Statements for the Third Quarter of the Fiscal Year Ending September 2026 (Japanese GAAP)Sources

Precision System Science Co., Ltd. has released consolidated financial statements for the three-month period ending September 30, 2026 (July 1 to September 30, 2026). This report is prepared in accordance with Japanese GAAP and presents an overview of key financial metrics and performance.

FY2026 Consolidated Financial ResultsSources

For the fiscal year ended June 30, 2026, net sales rose 11.2% year over year to ¥5,216 million. The company reported operating profit of ¥201 million, ordinary profit of ¥155 million, and profit attributable to owners of the parent of ¥394 million, compared with losses in the previous fiscal year.

Precision System Science Reports FY2026 ResultsSources

Precision System Science reported consolidated revenue of approximately ¥5.2 billion for fiscal 2026, up year over year. Operating profit was approximately ¥200 million, down year over year. Net income was approximately ¥155 million, turning profitable from a loss the previous year.

Nine-Month Results to March 31, 2026Sources

Net sales rose to ¥3,778 million for the nine months ended March 31 2026, up from ¥3,462 million in the same period last year. Operating profit fell to ¥134 million from ¥83 million, while ordinary profit and profit attributable to owners were ¥109 million and ¥201 million, respectively, both lower than the prior year. Basic earnings per share were ¥7.37, with no diluted EPS disclosed.

Precision System Science's 9-month results for the fiscal year ending March 2026Sources

During the nine months of the fiscal year ending March 2026, revenue was 3,778 million yen, an increase of 9.1% year-over-year, and net profit was 109 million yen.

Six-Month Results to Dec 31, 2025Sources

For the six months ended December 31 2025, the company reported net sales of ¥2,534 million, up from ¥2,197 million in the prior year, and an operating profit margin of 15.3 %. Ordinary profit turned positive at ¥84 million, compared with a ¥111 million loss in the same period last year, while profit attributable to owners of parent rose to ¥69 million from a ¥119 million loss. Basic earnings per share were ¥2.27, versus a loss of ¥5.65 in the previous year.

Precision System Science's June 2025 Semi-Annual Financial ResultsSources

The consolidated performance for the six months ending December 2025 was sales of 2,534 million yen and operating profit of 84 million yen, an increase compared to the same period last year. Net profit was 69 million yen, with basic earnings per share of 2.27 yen.

Precision System Science's March 2025 Quarterly ResultsSources

In the first quarter of FY2025, sales increased year-over-year, operating profit improved, but net profit remained a loss.

Precision System Science Address UpdateSources

The address display of Odate Regent Center in Odate City, Akita Prefecture has been updated, but there are no changes to the location or contact information.

Nine-Month Results to March 31, 2025Sources

Net sales rose to ¥3,462 million in the nine months ended March 31, 2025, up from ¥2,941 million in the same period last year. Operating profit margin improved to 17.7% from a negative 30.1% in the prior year. Ordinary profit and profit attributable to owners of parent were ¥(83) million and ¥(97) million, respectively, compared with ¥(639) million and ¥(685) million in the prior year. Basic earnings per share were ¥(6.75) versus ¥(23.81) in the prior year.

§08

Public records

GOV
National Tax Agency basic information9040001037483
Source: National Tax Agency Corporate Number Publication Site, basic three itemsSources
Trade name
プレシジョン・システム・サイエンス株式会社
Trade name (kana)
プレシジョンシステムサイエンス
Name in English
Corporation type
301
Address
〒271-0064 千葉県松戸市上本郷88番地
Postal code
2710064
Prefecture code
12
City code
207
Address outside Japan
Prefecture in English
City in English
Address outside Japan in English
Corporate number assignment date
2015-10-05
Update date
2018-06-27
Change date
2016-07-08
Registry closure date
Reason for registry closure
Successor corporate number
Details of the change
平成28年6月30日千葉県松戸市上本郷88番地ジェネテイン株式会社(8010001108866)を合併
Latest record
1
Excluded from search
0
Processing type
71
Correction type
1
Trade name image ID
Address image ID
Sequence number
1248089
METI gBizINFO9040001037483
Source: gBizINFO (Ministry of Economy, Trade and Industry)Sources
Corporate number
9040001037483
Trade name
プレシジョン・システム・サイエンス株式会社
Trade name (kana)
プレシジョンシステムサイエンス
Trade name (alphabet)
Registry closure date
Reason for registry closure
Registered address
千葉県松戸市上本郷88番地
Postal code
2710064
Prefecture
千葉県
Prefecture code
12
City or district
松戸市
City code
207
Street address
上本郷88番地
Organisation type
301
Processing type
71
Correction type
1
Status
Representative
代表取締役社長 杉山 悠
Capital
100000000
Employees
126
Employees (male)
Employees (female)
Business summary
Website URL
Year founded
Business category
Date established
Unified government qualification - grade
Unified government qualification - business items
Update date
2018-06-27
Key information
9040001037483
§09

Sources & updates

SOURCES
↑